AU565087B2 - 1,4-dihydro-4-oxonaphthyridine derivatives - Google Patents

1,4-dihydro-4-oxonaphthyridine derivatives

Info

Publication number
AU565087B2
AU565087B2 AU41650/85A AU4165085A AU565087B2 AU 565087 B2 AU565087 B2 AU 565087B2 AU 41650/85 A AU41650/85 A AU 41650/85A AU 4165085 A AU4165085 A AU 4165085A AU 565087 B2 AU565087 B2 AU 565087B2
Authority
AU
Australia
Prior art keywords
dihydro
oxonaphthyridine derivatives
oxonaphthyridine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU41650/85A
Other languages
English (en)
Other versions
AU4165085A (en
Inventor
Isao Kitayama
Yoriko Kobayashi
Yoshinori Konishi
Shinzaburo Minami
Hideyoshi Nagaki
Hirokazu Narita
Jun Nitta
Isamu Saikawa
Mikako Shinagawa
Yasuo Watanabe
Akira Yotsuju
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13845280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU565087(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of AU4165085A publication Critical patent/AU4165085A/en
Application granted granted Critical
Publication of AU565087B2 publication Critical patent/AU565087B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU41650/85A 1984-04-26 1985-04-24 1,4-dihydro-4-oxonaphthyridine derivatives Expired AU565087B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59-84963 1984-04-26
JP59084963A JPS60228479A (ja) 1984-04-26 1984-04-26 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU81804/87A Division AU612993B2 (en) 1984-04-26 1987-11-25 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same

Publications (2)

Publication Number Publication Date
AU4165085A AU4165085A (en) 1985-10-31
AU565087B2 true AU565087B2 (en) 1987-09-03

Family

ID=13845280

Family Applications (2)

Application Number Title Priority Date Filing Date
AU41650/85A Expired AU565087B2 (en) 1984-04-26 1985-04-24 1,4-dihydro-4-oxonaphthyridine derivatives
AU81804/87A Expired AU612993B2 (en) 1984-04-26 1987-11-25 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU81804/87A Expired AU612993B2 (en) 1984-04-26 1987-11-25 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same

Country Status (30)

Country Link
JP (1) JPS60228479A (id)
KR (1) KR870001693B1 (id)
AR (1) AR241911A1 (id)
AT (2) AT389698B (id)
AU (2) AU565087B2 (id)
BE (1) BE902279A (id)
CH (1) CH673458A5 (id)
CS (1) CS250684B2 (id)
DD (1) DD238795A5 (id)
DE (2) DE3546658C2 (id)
DK (1) DK165877C (id)
EG (1) EG17339A (id)
ES (2) ES8700256A1 (id)
FI (1) FI80453C (id)
FR (2) FR2563521B1 (id)
GB (2) GB2158825B (id)
HU (2) HU194226B (id)
ID (1) ID21142A (id)
IL (1) IL75021A (id)
IT (1) IT1209953B (id)
LU (1) LU85871A1 (id)
NL (2) NL187314C (id)
NO (1) NO162238C (id)
NZ (1) NZ211895A (id)
PH (3) PH22801A (id)
PL (1) PL147392B1 (id)
PT (1) PT80349B (id)
RO (2) RO95509B (id)
SE (2) SE463102B (id)
ZA (1) ZA853102B (id)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
AU589978B2 (en) * 1985-06-26 1989-10-26 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6172753A (ja) * 1984-09-18 1986-04-14 Dainippon Pharmaceut Co Ltd ピリジルケトン誘導体
AT392789B (de) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
US4859776A (en) * 1988-03-11 1989-08-22 Abbott Laboratories (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
CA2100242A1 (en) * 1991-01-14 1992-07-15 Soon K. Moon Quinolone compounds and processes for preparation thereof
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
KR940014395A (ko) * 1992-12-09 1994-07-18 강박광 신규한 퀴놀론 유도체 및 그의 제조방법
KR0148277B1 (ko) * 1993-01-18 1998-11-02 채영복 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
AU4272793A (en) * 1993-04-24 1994-11-21 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
DE69531305T2 (de) * 1994-10-20 2004-05-13 Wakunaga Seiyaku K.K. Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
EP0897919B1 (en) 1996-04-19 2004-06-16 Wakunaga Pharmaceutical Co., Ltd. Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents containing the same as the active ingredient
EP0935600A1 (de) * 1996-10-30 1999-08-18 Bayer Ag Verfahren zur herstellung von naphthyridinverbindungen und neue zwischenprodukte
DE19713506A1 (de) 1997-04-01 1998-10-08 Bayer Ag Verfahren zur Herstellung von 2,6-Dichlor-5-fluornicotinonitril und die chemische Verbindung 3-Cyano-2-hydroxy-5-fluorpyrid-6-on-mononatriumsalz sowie dessen Tautomere
CN1343128B (zh) 1999-03-17 2010-04-21 第一制药株式会社 药物组合物
US6441182B1 (en) 1999-06-10 2002-08-27 Bayer Aktiengesellschaft Method for the production of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid
WO2001017991A1 (fr) 1999-09-02 2001-03-15 Wakunaga Pharmaceutical Co., Ltd. Derive d'acide quinolinecarboxylique ou son sel
EP1313708A1 (en) * 2000-08-29 2003-05-28 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
KR100981351B1 (ko) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 7-클로로-1-사이클로프로필-6-플루오로-4-옥소-1,4-디하이드로-1,8-나프티리딘-3-카복실산의 제조방법
CN101792443A (zh) * 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途
JOP20190045A1 (ar) 2016-09-14 2019-03-14 Bayer Ag مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها.
CN114369092A (zh) * 2021-12-20 2022-04-19 赤峰万泽药业股份有限公司 甲苯磺酸妥舒沙星及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4382937A (en) 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
IL74064A (en) * 1984-01-26 1988-09-30 Abbott Lab 1,7-disubstituted-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and antibacterial compositions containing them
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
AU589978B2 (en) * 1985-06-26 1989-10-26 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives

Also Published As

Publication number Publication date
JPS6320828B2 (id) 1988-04-30
AR241911A1 (es) 1993-01-29
IL75021A0 (en) 1985-08-30
GB2191776B (en) 1990-03-28
PL147392B1 (en) 1989-05-31
NO162238C (no) 1989-12-06
AT389698B (de) 1990-01-10
AU8180487A (en) 1988-03-24
CS250684B2 (en) 1987-05-14
KR870001693B1 (ko) 1987-09-24
FR2614620B1 (fr) 1990-03-09
IL75021A (en) 1994-01-25
HU197571B (en) 1989-04-28
DK185685A (da) 1985-10-27
RO95509A (ro) 1988-09-30
FR2563521B1 (fr) 1989-02-03
KR850007596A (ko) 1985-12-07
FI80453B (fi) 1990-02-28
IT8548002A0 (it) 1985-04-26
SE501412C2 (sv) 1995-02-13
FR2563521A1 (fr) 1985-10-31
HU194226B (en) 1988-01-28
NL9100648A (nl) 1991-08-01
NO162238B (no) 1989-08-21
RO95509B (ro) 1988-10-01
EG17339A (en) 1989-06-30
HUT38634A (en) 1986-06-30
ATA267888A (de) 1989-09-15
GB2158825A (en) 1985-11-20
SE8804586D0 (sv) 1988-12-20
PL253108A1 (en) 1985-12-17
LU85871A1 (en) 1985-12-16
SE8502017D0 (sv) 1985-04-25
DK185685D0 (da) 1985-04-25
ES8700256A1 (es) 1986-09-16
CH673458A5 (id) 1990-03-15
GB8716897D0 (en) 1987-08-26
BE902279A (fr) 1985-10-25
PH25228A (en) 1991-03-27
DK165877C (da) 1993-06-21
RO91871A (ro) 1987-07-30
DK165877B (da) 1993-02-01
FI80453C (fi) 1990-06-11
NL187314C (nl) 1991-08-16
NO851643L (no) 1985-10-28
DE3546658C2 (id) 1992-04-02
SE8502017L (sv) 1985-10-27
ES8706673A1 (es) 1987-07-01
GB2191776A (en) 1987-12-23
ES551538A0 (es) 1987-07-01
PH25046A (en) 1991-01-28
ATA122485A (de) 1989-06-15
PH22801A (en) 1988-12-12
NZ211895A (en) 1988-07-28
PT80349A (en) 1985-05-01
GB2158825B (en) 1989-01-25
DE3514076C2 (id) 1989-03-30
DE3514076A1 (de) 1985-10-31
JPS60228479A (ja) 1985-11-13
SE8804586L (sv) 1988-12-20
ES542584A0 (es) 1986-09-16
PT80349B (pt) 1987-09-30
IT1209953B (it) 1989-08-30
AU612993B2 (en) 1991-07-25
AT390258B (de) 1990-04-10
GB8510297D0 (en) 1985-05-30
FI851637L (fi) 1985-10-27
NL8501172A (nl) 1985-11-18
FR2614620A1 (fr) 1988-11-04
DD238795A5 (de) 1986-09-03
SE463102B (sv) 1990-10-08
ZA853102B (en) 1986-12-30
ID21142A (id) 1999-04-29
FI851637A0 (fi) 1985-04-25
AU4165085A (en) 1985-10-31
RO91871B (ro) 1987-07-31

Similar Documents

Publication Publication Date Title
GB2153821B (en) 3-imidazolylmethyl-1,2,3,9-tetrahydro-4h-carbazol-4-one derivatives
AU586182B2 (en) Analgesic 1,2-Benzisothiazol-3-ylpiperazine derivatives
AU565087B2 (en) 1,4-dihydro-4-oxonaphthyridine derivatives
AU8065587A (en) 3,4-dihydro-3-phenyl-2H-1-benzopyran derivatives
AU589931B2 (en) 1,2,4-triazole derivatives
AU7368187A (en) 1,2,3,6-tetrahydro-5-nitro-pyrimidine derivatives
AU4744985A (en) 1,4-dihydropyridine derivatives
AU566416B2 (en) 1,8- - naphthyridine or hydroquineline derivatives
AU6675186A (en) Substituted 5,6-dialkoxyquinazoline derivatives
AU566419B2 (en) U/,3-oxazoliding-2-one derivatives
AU576279B2 (en) 2,4-diamino-pyrimidines
AU576393B2 (en) 1,2,4 - triazolo - carbamate compounds
AU574806B2 (en) 2,2,6,6 - tetramethyl - 4 - piperidinyl derivatives
AU2956484A (en) Benzoxadiazol-4-yl-1,4 dibyropyridine derivatives
AU577140B2 (en) 2,4-diamino-6-difluoromethylthio-1,3,5-triazine derivatives
EP0183975A3 (en) 5,6,7,8-tetrafluoroanthraquinone derivatives
AU3808385A (en) 1,3,2-dioxaborinanes
HK185395A (en) 9,11-Epoxy-21-hydroxypregnane derivatives
AU7519987A (en) 1,1,2-triaryl-1-alkene derivatives
AU4023085A (en) 1,2,4-triazacycloalkadiene derivatives
AU577152B2 (en) 1,4-dihidropyridine-3,5-dicarboxylate derivatives
AU564985B2 (en) 1,4-aminoalkylamino-9h-thioxanthen-9-ones
AU4089185A (en) 1,3-benzodioxole derivatives
AU4004085A (en) 3-mercapto-1,2,4-triazacycloalkadiene derivatives
AU572869B2 (en) 1,6-naphthyridin derivatives